Leverages its strong technology and intellectual property portfolio in the exciting new field of RNA interference (RNAi) for the treatment and prevention of opthalmic diseases.
« Back to Client Directory
Leverages its strong technology and intellectual property portfolio in the exciting new field of RNA interference (RNAi) for the treatment and prevention of opthalmic diseases.